Cough Syrups to require Doctor’s Prescription in India under New Government Drug Rules
The Union Health Ministry has amended drug regulations to make all syrup-based medicines, including cough syrups, available only on a doctor’s prescription, in a major move to strengthen pharmaceutical oversight and patient safety in India.
The decision has been implemented through the Drugs (Fifth Amendment) Rules, 2026, which have been officially notified in the gazette and came into effect immediately upon publication. Under the revised rules, “syrups” have been removed from the exempted category in Schedule K of the Drugs Rules, 1945.
Schedule K earlier listed certain drug categories that were exempt from specific provisions related to manufacture, sale, and distribution under the Drugs and Cosmetics Act. With this amendment, syrup-based formulations will now fall under stricter regulatory control.
According to official sources, the move is aimed at improving traceability, quality monitoring, and controlled distribution of liquid oral medicines, especially cough syrups, which have come under increased scrutiny in recent years due to safety concerns and contamination-related incidents reported in India and abroad.
The amendment follows a draft notification issued earlier for public feedback, and the final decision was taken after considering stakeholder inputs and consultation with the Drugs Technical Advisory Board (DTAB), the apex body on technical drug-related matters.
Health officials said the new framework is expected to ensure stricter compliance by manufacturers and sellers, while enhancing patient safety through better prescription-based monitoring of syrup medicines.
The decision marks a significant regulatory tightening in India’s pharmaceutical sector, particularly for over-the-counter access to liquid medicines commonly used for cough and cold treatment.
